Adalimumab biosimilar in inflammatory bowel disease. Fiorino G, Allocca M, Danese S. Lancet Gastroenterol Hepatol 2021 Aug 10. pii: S2468-1253(21)00266.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fiorino G, Allocca M, Danese S. Adalimumab biosimilar in inflammatory bowel disease. Lancet Gastroenterol Hepatol 2021 Aug 10. pii: S2468-1253(21)00266.
PMID: 34388361